NEW YORK, Jan. 30, 2017 /PRNewswire/ -- The U.S. Food & Drug Administration (FDA) has confirmed that Hyland's homeopathic teething tablets contain inconsistent levels of belladonna which may far exceed the amount claimed on the label. In a statement issued on January 27, 2017 the agency advised consumers to stop using these products immediately and throw them away. While the FDA has asked the Standard Homeopathic Company to conduct a teething tablets recall for the Hyland's products, it has not yet agreed to do so.
"Our Firm has received inquiries from families whose children suffered complications consistent with belladonna toxicity following ingestion of homeopathic teething tablets and gels. We are pleased that the FDA continues to take steps to inform the public of the risks potentially associated with these products," says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is now offering free, no-obligation legal reviews to families whose children may have been harmed by homeopathic teething medications.
Teething Tablets Deaths and Injuries
Homeopathic teething tablets and gels are marketed to relieve teething pain in infants and children. These products often contain belladonna, which in small amounts has a sedative effect. However, excessive levels of belladonna can be poisonous, resulting in seizures and other adverse events. Symptoms of belladonna toxicity include:
- Difficulty breathing
- Excessive sleepiness
- Muscle weakness
- Skin flushing
- Difficulty urinating
This is not the first time Hyland's products have been found to contain inconsistent amounts of belladonna. Hyland's homeopathic teething remedies were recalled in 2010, after they were linked adverse events suggestive of belladonna poisoning.
The FDA initially warned against the use of homeopathic teething tablets and gels in September 2016, after such products were linked to hundreds of adverse events, including seizures. The agency was also aware of 10 infant deaths potentially associated with homeopathic teething remedies. While several retailers subsequently removed such products from their store shelves, Standard Homeopathic announced it would stop marketing Hyland's teething tablets in the U.S. In November, Raritan Pharmaceuticals announced a recall of its homeopathic teething tablets and ear pain liquids after tests suggested they might contain varying amounts of belladonna. Thus far, the Raritan products have not been linked to any injuries.
Infants and children who suffered complications allegedly related to homeopathic teething medications may be entitled to compensation for injury-related damages. To learn more about filing a teething tablets lawsuit, please visit Bernstein Liebhard LLP's website, or call 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3.5 billion on behalf of our clients. Bernstein Liebhard LLP is honored to once again be named to The National Law Journal's "Plaintiffs' Hot List," recognizing the top plaintiffs firms in the country. This year's nomination marks the thirteenth year the firm has been named to this prestigious annual list.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2017 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
SOURCE Bernstein Liebhard LLP